InvestorsHub Logo
Followers 58
Posts 10124
Boards Moderated 1
Alias Born 09/21/2016

Re: sab63090 post# 415739

Wednesday, 05/17/2023 10:30:47 AM

Wednesday, May 17, 2023 10:30:47 AM

Post# of 461375
sab63090

That is encouraging to me...appreciate this as evidence that it's not just forward thinking, but rather ongoing...!!!



sab63090..appreciate your process observation and agree. I see Dr.M. as a leader for continuous learning-thinking. We note that this is a valued but tough path to sustain since WS values the end game-(FDA APPROVAL) of something(anything). So...there is a dilemma, a kind of conflict on..."Is it soup yet??" CNS diseases present perhaps the most complex set of links . IMO, the next best result will hinge around results that clearly show improved , human Quality of Life. Thankfully, Dr.M. and staff/team present a unique and valued type of personal and technical leadership/courage. We are lucky.

So far, IMO, the CNS diseases (FDA BASED) statistical process search has been better at providing guidance on what is NOT the REAL SOLUTION, which plays well with the WS herd model of (How To) make $$$.

AVXL is probably the leader on the trail in search of a real (top shelf) CNS disease root cause/solution...hopefully in our lifetime. Learning how to value ($$$$$) the interim solutions along the way is tiresome but required, IMO. WE GOT THE BIG LEAD...IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News